These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6284867)
1. Time of synthesis and cellular location of Epstein-Barr virus-specified polypeptides radioimmunoprecipitated from iododeoxyuridine-induced Burkitt lymphoma/somatic cell hybrids. Durnford JM; Scanlon PA; Glaser R J Gen Virol; 1982 May; 60(Pt 1):39-48. PubMed ID: 6284867 [TBL] [Abstract][Full Text] [Related]
2. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus. Fresen KO; zur Hausen H Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313 [TBL] [Abstract][Full Text] [Related]
3. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. Moar MH; Ber R; Klein G; Westman A; Eriksson I Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545 [TBL] [Abstract][Full Text] [Related]
4. Host cell regulation of induction of Epstein-Barr virus. Glaser R; Nonoyama M J Virol; 1974 Jul; 14(1):174-6. PubMed ID: 4365330 [TBL] [Abstract][Full Text] [Related]
5. Transcription of Epstein-Barr virus genomes in human lymphoblastoid cells and in somatic-cell hybrids of Burkitt's lymphoma. Nonoyama M; Tanaka A; Silver S; Glaser R IARC Sci Publ (1971); 1978; (24 Pt 1):559-63. PubMed ID: 221360 [TBL] [Abstract][Full Text] [Related]
6. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle. Klein G; Clements G; Zeuthen J; Westman A Int J Cancer; 1976 Jun; 17(6):715-24. PubMed ID: 59708 [TBL] [Abstract][Full Text] [Related]
7. Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells. Glaser R; Rapp F J Virol; 1972 Aug; 10(2):288-96. PubMed ID: 4342246 [TBL] [Abstract][Full Text] [Related]
8. Interferon enhances the expression of epstein-Barr virus early antigen in Daudi cells. Tovey MG; Dron M; Gresser I J Gen Virol; 1982 May; 60(Pt 1):31-8. PubMed ID: 6178801 [TBL] [Abstract][Full Text] [Related]
9. Studies on the association of the Epstein-Barr virus genome with chromosomes in human (Burkitt)/mouse hybrid cells. Glaser R; Croce C; Nonoyama M IARC Sci Publ (1971); 1978; (24 Pt 1):565-70. PubMed ID: 221361 [TBL] [Abstract][Full Text] [Related]
10. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. Klein G; Zeuthen J; Ber R; Ernberg I J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide. Mueller-Lantzsch N; Yamamoto N J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267 [TBL] [Abstract][Full Text] [Related]
12. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids. Klein G; Vilcek J J Gen Virol; 1980 Jan; 46(1):111-7. PubMed ID: 6243338 [TBL] [Abstract][Full Text] [Related]
13. [Studies on the synthesis of Epstein-Barr virus-related antigens induced by superinfection]. Fujiwara S Hokkaido Igaku Zasshi; 1984 Sep; 59(5):586-602. PubMed ID: 6096242 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of Epstein-Barr virus antigens and DNA in activated Burkitt somatic cell hybrids. Glaser R; Nonoyama M; Decker B; Rapp F Virology; 1973 Sep; 55(1):62-9. PubMed ID: 4353957 [No Abstract] [Full Text] [Related]
15. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin. Shapiro IM; Luka J; Andersson-Anvret M; Klein G Intervirology; 1979; 12(1):19-25. PubMed ID: 227812 [TBL] [Abstract][Full Text] [Related]
16. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment. Shapiro IM; Andersson-Anvret M; Klein G Intervirology; 1978; 10(2):94-101. PubMed ID: 209000 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of D and R components of Epstein-Barr virus early antigen after superinfection and after induction with 5-iododeoxyuridine. Simonová I; Závadová H; Vonka V Acta Virol; 1977 May; 21(3):184-8. PubMed ID: 18915 [TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine. Yamamoto N; Mueller-Lantzsch N; zur Hausen H Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-induced polypeptides: a comparative study with superinfected Raji, IUdR-Treated, and N-butyrate-treated P3HR-1 cells. Kawanishi M; Sugawara K; Ito Y Virology; 1981 Feb; 109(1):72-81. PubMed ID: 6258314 [No Abstract] [Full Text] [Related]
20. Expression of latent Epstein-Barr virus genomes in human epithelial/Burkitt's lymphoblastoid hybrid cells. Nonoyama M; Tanaka A; Glaser R IARC Sci Publ (1971); 1978; (20):397-402. PubMed ID: 215523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]